Galmed Pharmaceuticals - The Catalyst will hit hard !

I was in DRUG before the move last year when it moved from 1.50$ to over 70$ per share. Most of the time, these huge movers are building pressure quietly before they explode.

In my opinion, this is currently what is going on with GLMD, more shorts are piling in and the share price is still going slightly up. Basically, they are getting trapped at a higher price.

The company released in their latest earning report that they had 20M$ in cash which would last more than 12months. Dilution risk is almost 0.

From an opportunity point of view their aramchol project is now in phase 3 and they could release some major updates about the commercialization part in which they would compete agaisnt Ozempic BUT with a major advantage: the use of pills instead of injections. Whether they decide to sell it themselves or to be bought from a bigger bio company, this sector is worth billions yearly and would create insane shareholder value.

I bought in at 1.40$ and avg up here on any dip. 3.39M market cap is dirt cheap for their potential in the weight loss market. These companies can run 500-1000% in matter of few hours.